日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

MicroRNA Expression Analysis and Biological Pathways in Chemoresistant Non-Small Cell Lung Cancer

化疗耐药性非小细胞肺癌中microRNA表达分析及生物学通路

Papadaki, Chara; Mortoglou, Maria; Boukouris, Aristeidis E; Gourlia, Krystallia; Markaki, Maria; Lagoudaki, Eleni; Koutsopoulos, Anastasios; Tsamardinos, Ioannis; Mavroudis, Dimitrios; Agelaki, Sofia

LKB1 Loss Correlates with STING Loss and, in Cooperation with β-Catenin Membranous Loss, Indicates Poor Prognosis in Patients with Operable Non-Small Cell Lung Cancer

LKB1 缺失与 STING 缺失相关,并且与 β-catenin 膜丢失共同作用,预示着可手术切除的非小细胞肺癌患者预后不良。

Lagoudaki, Eleni D; Koutsopoulos, Anastasios V; Sfakianaki, Maria; Papadaki, Chara; Manikis, Georgios C; Voutsina, Alexandra; Trypaki, Maria; Tsakalaki, Eleftheria; Fiolitaki, Georgia; Hatzidaki, Dora; Yiachnakis, Emmanuel; Koumaki, Dimitra; Mavroudis, Dimitrios; Tzardi, Maria; Stathopoulos, Efstathios N; Marias, Kostas; Georgoulias, Vassilis; Souglakos, John

Corrigendum: MicroRNAs regulating tumor immune response in the prediction of the outcome in patients with breast cancer

更正:microRNA调控肿瘤免疫反应在预测乳腺癌患者预后中的作用

Thomopoulou, Konstantina; Papadaki, Chara; Monastirioti, Alexia; Koronakis, George; Mala, Anastasia; Kalapanida, Despoina; Mavroudis, Dimitrios; Agelaki, Sofia

Correction: Prediction of outcome in patients with non-small cell lung cancer treated with second line PD-1/PDL-1 inhibitors based on clinical parameters: Results from a prospective, single institution study

更正:基于临床参数预测接受二线PD-1/PDL-1抑制剂治疗的非小细胞肺癌患者的预后:一项前瞻性单中心研究的结果

Rounis, Konstantinos; Makrakis, Dimitrios; Papadaki, Chara; Monastirioti, Alexia; Vamvakas, Lambros; Kalbakis, Konstantinos; Gourlia, Krystallia; Xanthopoulos, Iordanis; Tsamardinos, Ioannis; Mavroudis, Dimitrios; Agelaki, Sofia

Effect of body tissue composition on the outcome of patients with metastatic non-small cell lung cancer treated with PD-1/PD-L1 inhibitors

身体组织成分对接受PD-1/PD-L1抑制剂治疗的转移性非小细胞肺癌患者预后的影响

Makrakis, Dimitrios; Rounis, Konstantinos; Tsigkas, Alexandros-Pantelis; Georgiou, Alexandra; Galanakis, Nikolaos; Tsakonas, George; Ekman, Simon; Papadaki, Chara; Monastirioti, Alexia; Kontogianni, Meropi; Gioulbasanis, Ioannis; Mavroudis, Dimitris; Agelaki, Sofia

Correction to: Circulating microRNAs in the early prediction of disease recurrence in primary breast cancer

更正:循环microRNA在原发性乳腺癌疾病复发早期预测中的作用

Papadaki, Chara; Stratigos, Michalis; Markakis, Georgios; Spiliotaki, Maria; Mastrostamatis, Georgios; Nikolaou, Christoforos; Mavroudis, Dimitrios; Agelaki, Sofia

Plasma-Based microRNA Expression Analysis in Advanced Stage NSCLC Patients Treated with Nivolumab

接受纳武利尤单抗治疗的晚期非小细胞肺癌患者血浆微RNA表达分析

Monastirioti, Alexia; Papadaki, Chara; Kalapanida, Despoina; Rounis, Konstantinos; Michaelidou, Kleita; Papadaki, Maria A; Mavroudis, Dimitrios; Agelaki, Sofia

TLR4 and pSTAT3 Expression on Circulating Tumor Cells (CTCs) and Immune Cells in the Peripheral Blood of Breast Cancer Patients: Prognostic Implications.

乳腺癌患者外周血中循环肿瘤细胞 (CTC) 和免疫细胞上的 TLR4 和 pSTAT3 表达:预后意义

Papadaki Maria A, Monastirioti Alexia, Apostolopoulou Christina A, Aggouraki Despoina, Papadaki Chara, Michaelidou Kleita, Vassilakopoulou Maria, Alexakou Katerina, Mavroudis Dimitrios, Agelaki Sofia

A Prognostic Role for Circulating microRNAs Involved in Macrophage Polarization in Advanced Non-Small Cell Lung Cancer

循环microRNA在晚期非小细胞肺癌巨噬细胞极化中的预后作用

Monastirioti, Alexia; Papadaki, Chara; Rounis, Konstantinos; Kalapanida, Despoina; Mavroudis, Dimitrios; Agelaki, Sofia

MicroRNAs Regulating Tumor Immune Response in the Prediction of the Outcome in Patients With Breast Cancer

微小RNA调控肿瘤免疫反应在预测乳腺癌患者预后中的作用

Thomopoulou, Konstantina; Papadaki, Chara; Monastirioti, Alexia; Koronakis, George; Mala, Anastasia; Kalapanida, Despoina; Mavroudis, Dimitrios; Agelaki, Sofia